Study Shows Improved Quality of Life and Reduced Symptoms In Patients Treated with Medtronic Cryoballoon

DUBLIN and MUNICH — August 28, 2018 — Medtronic plc (NYSE:MDT) today announced new findings from the CRYO4PERSISTENT AF clinical trial demonstrating improved quality of life, reduced symptoms from abnormal heart rhythms, and low incidence of reinterventions and repeat ablation procedures.

Han awarded the inaugural 2018 DeHaan Award for Innovation in Cardiology

Vienna, VA (August 13, 2018) — B. Kelly Han, MD, is the recipient of the inaugural 2018 DeHaan Award for Innovation in Cardiology, which includes a $200,000 grant.

Thumbnail

Jonathan R. Lindner elected president of American Society of Echocardiography

Jonathan R. Lindner, MD, was elected president of the American Society of Echocardiography (ASE) at the ASE’s 29th Annual Scientific Sessions in Nashville, Tennessee.

Thumbnail

Jonathan Lindner elected president of the American Society of Echocardiography

The 17,000-member American Society of Echocardiography (ASE) named Jonathan R. Lindner, MD, president of the organization during its 29th annual scientific sessions in Nashville, Tennessee.

Thumbnail

FDA-approved AI echocardiogram software bests cardiologists in reducing LVEF variability

A deep-learning software that can automatically calculate left ventricular ejection fraction (LVEF) with less variability than a cardiologist recently received approval from the U.S. Food and Drug Administration (FDA).

Thumbnail

AI-assisted echocardiogram analysis improves reproducibility of LVEF measurements

A deep-learning algorithm can automatically calculate left ventricular ejection fraction (LVEF) with less variability than cardiologists, according to a study presented June 25 at the American Society of Echocardiography’s annual scientific sessions.
Thumbnail

SNMMI backs updated ASNC guidelines on SPECT MPI

New 2018 guidelines for myocardial perfusion imaging (MPI) protocols on conventional and novel single photon emission computed tomography (SPECT) for nuclear cardiology practitioners has received praise from the Society for Nuclear Medicine and Molecular Imaging (SNMMI).

Getinge announces results from SEMPER FI pilot study of intra-aortic balloon pump showing numerical trend toward reduced mortality in patients with extensive myocardial infarction and persistent ischemia

WAYNE, N.J., May 25, 2018 — Getinge, a leading global provider of innovative medical technology, today announced results from the Survival Improvement in Extensive Myocardial Infarction with PERsistent Ischemia Following IABP Implantation (SEMPER FI) pilot study.